XML 58 R48.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION - Schedule of Total Revenues and Disaggregates Net Product Revenues by Product (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue from External Customer [Line Items]    
Revenue $ 745,145 $ 648,833
Net product revenues    
Revenue from External Customer [Line Items]    
Revenue 734,644 637,815
VOXZOGO    
Revenue from External Customer [Line Items]    
Revenue 213,754 152,889
VIMIZIM    
Revenue from External Customer [Line Items]    
Revenue 188,346 192,520
NAGLAZYME    
Revenue from External Customer [Line Items]    
Revenue 114,290 105,629
PALYNZIQ    
Revenue from External Customer [Line Items]    
Revenue 93,269 75,709
ALDURAZYME    
Revenue from External Customer [Line Items]    
Revenue 48,977 35,262
BRINEURA    
Revenue from External Customer [Line Items]    
Revenue 40,362 39,047
KUVAN    
Revenue from External Customer [Line Items]    
Revenue 25,136 35,910
ROCTAVIAN    
Revenue from External Customer [Line Items]    
Revenue 10,510 849
Royalty and other revenues    
Revenue from External Customer [Line Items]    
Revenue $ 10,501 $ 11,018